Medicine and Dentistry
Promoter Region
100%
Pancreas Adenocarcinoma
85%
Bilirubin
85%
Cell-Free DNA
78%
Phototherapy
64%
Biological Marker
49%
Neonates
45%
Colorectal Cancer
42%
Secreted Frizzled-Related Protein 1
35%
Diagnosis
33%
Neoplasm
28%
Diseases
27%
Gemcitabine
24%
High-Performance Liquid Chromatography
24%
Neonatal Jaundice
21%
Randomized Controlled Trial
21%
Bilirubin Glucuronide
21%
Radiation Therapy
21%
Chronic Hepatitis C
21%
Peginterferon Alpha
21%
Ribavirin
21%
Alpha2a Interferon
21%
Liquid Biopsy
21%
Symptom
21%
Epileptic Absence
21%
Liver Cirrhosis
21%
Circulating Tumor DNA
18%
Proportional Hazards Model
17%
Methylation
16%
Hyperbilirubinemia
16%
Malignant Neoplasm
14%
Pancreatic Ductal Adenocarcinoma
13%
Bisulfite
13%
Pediatric Research
12%
Anatomy
10%
DNA Template
10%
Cancer Radiotherapy
10%
Echography
10%
Biopsy
10%
Oropharynx
10%
Multivariate Analysis
10%
Hepatitis C Treatment
10%
Cancer Staging
10%
Head and Neck Cancer
10%
Pancreas Cancer
10%
Squamous Cell Carcinoma
10%
Polymerase Chain Reaction
9%
Gestational Age
9%
Neonatal Hyperbilirubinemia
9%
Overall Survival
9%
Keyphrases
SFRP1
46%
Pancreatic Adenocarcinoma
44%
Promoter Methylation
42%
Bisulfite Treatment
30%
DNA Promoter Hypermethylation
28%
Blood Biomarkers
28%
Cell-free DNA (cfDNA)
26%
Gemcitabine
23%
Cell-free
21%
Photodiode
21%
DNA Hypermethylation
21%
Blood-based Marker
21%
Obesity Genes
21%
Turquoise
21%
Light-emitting Diode (LED) Lamps
21%
Blue Light-emitting Diodes
21%
Pegylated Interferon alfa-2a
21%
HCV RNA
21%
Sonographic Evaluation
21%
Deep Vein
21%
Sonography
21%
High Recovery
21%
Benign Course
21%
Methylated DNA
21%
Diglucuronide
21%
Clinical Target Volume
21%
Methylation Markers
21%
Hypermethylated DNA
21%
External Validation Study
21%
Prognostic Efficacy
21%
Prognostic Marker
21%
Pancreatic Ductal Adenocarcinoma
21%
Isomer Distribution
21%
Nucleocapsid Protein
21%
G1691A
17%
Acute Respiratory Symptoms
14%
Presumptive Diagnosis
14%
Cox Regression
14%
DNA Promoter
14%
Fluorescent Light
12%
Photoisomers
12%
Prothrombin G20210A mutation
12%
Hepatitis
12%
Genotype A
12%
Genotype B
12%
Esterified
10%
Cytosine
10%
Bisulfite
10%
Deamination
10%
Geometric Margin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
85%
Bilirubin
64%
Secreted Frizzled Related Protein 1
57%
Biological Marker
46%
Colorectal Cancer
42%
Disease
32%
Gemcitabine
32%
Overall Survival
21%
Bilirubin Glucuronide
21%
Newborn Jaundice
21%
Fluorescent Lamp
21%
Chemotherapy
21%
Genetic Susceptibility
21%
Alpha2a Interferon
21%
Peginterferon Alpha
21%
Nucleocapsid Protein
21%
Bisulfite
17%
Progression Free Survival
10%
Pancreas Cancer
10%
Neoplasm
10%
Survival Time
10%
Cancer Staging
10%
Malignant Neoplasm
7%
Hyperbilirubinemia
6%